Gunaldi, M. Et Al. 2014. Evaluation of CYP2D6 Polymorphic Types and Their Effect on Tamoxifen Efficacy Among Turkish Tamoxifen Users with Breast Cancer. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.24, no.3 , 157-162.

Gunaldi, M., Erkisi, M., Afsar, C., Ercolak, V., Duman, B., PAYDAŞ, S., ... Kara, I.(2014). Evaluation of CYP2D6 Polymorphic Types and Their Effect on Tamoxifen Efficacy Among Turkish Tamoxifen Users with Breast Cancer. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.24, no.3, 157-162.

Gunaldi, Meral Et Al. "Evaluation of CYP2D6 Polymorphic Types and Their Effect on Tamoxifen Efficacy Among Turkish Tamoxifen Users with Breast Cancer," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.24, no.3, 157-162, 2014

Gunaldi, Meral Et Al. "Evaluation of CYP2D6 Polymorphic Types and Their Effect on Tamoxifen Efficacy Among Turkish Tamoxifen Users with Breast Cancer." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.24, no.3, pp.157-162, 2014

Gunaldi, M. Et Al. (2014) . "Evaluation of CYP2D6 Polymorphic Types and Their Effect on Tamoxifen Efficacy Among Turkish Tamoxifen Users with Breast Cancer." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.24, no.3, pp.157-162.

@article{article, author={Meral Gunaldi Et Al. }, title={Evaluation of CYP2D6 Polymorphic Types and Their Effect on Tamoxifen Efficacy Among Turkish Tamoxifen Users with Breast Cancer}, journal={UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI}, year=2014, pages={157-162} }